BioMarin Pharmaceutical Inc. (BMRN)
BMV
Closed
Oct 6, 2026
Day's Range
1,105.0052 wk Range
959.00Overview - BMRN - BioMarin Pharmaceutical Inc.
Key Statistics
Valuation
Enterprise Value
3.84T
P/E (Trailing)
‪172.38‬
PEG Ratio
‪-2.11‬
Price / Sales (TTM)
‪62.78‬
Price / Book
‪1.90‬
EV / EBITDA
‪336.62‬
Profitability
Gross Margin
‪79.50%‬
Profit Margin
‪2.14%‬
Operating Margin
‪21.16%‬
Return on Assets
‪3.25%‬
Return on Equity
‪1.18%‬
Ownership
Shares Outstanding
193.53M
Float
192.62M
Held by Insiders
‪0.34%‬
Held by Institutions
‪103.79%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪1,073.63‬
200-Day Avg
‪1,007.75‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BMRN - BioMarin Pharmaceutical Inc.
Peers - BMRN - BioMarin Pharmaceutical Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- BMRNBMVBioMarin Pharmaceutical Inc.213.89BMarket Cap+10.22%52-week change172.39P/E (Trailing)‪2.14%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt1.05TMarket Cap+10.77%52-week change36.36P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals, Inc.742.50BMarket Cap-51.02%52-week change53.47P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE American Depositary Share413.38BMarket Cap-18.50%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- ASND1NBMVAscendis Pharma A/S291.08BMarket Cap+3.50%52-week change19.80P/E (Trailing)‪70.84%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals, Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
- ARWRBMVArrowhead Pharmaceuticals, Inc.64.02BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
Profile Summary - BMRN - BioMarin Pharmaceutical Inc.
About
BioMarin Pharmaceutical Inc. is a global biotechnology company focused on developing and commercializing therapies for rare genetic and metabolic diseases. Its portfolio includes approved medicines and advanced treatments such as enzyme replacement therapies, gene therapies, and other specialized biologics designed…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
